Skip to main navigation

Secondary Header Menu

  • Publications
  • Newsroom
  • Careers
  • Contact
Cidara TherapeuticsCidara Therapeutics
Menu

Corporate Menu

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Careers
  • Pipeline
  • Rezafungin
    • Overview
    • Treatment
    • Prevention
    • Expanded Access Policy
  • Cloudbreak®
    • Overview
    • Influenza
    • HIV, RSV, SARS-CoV-2 and other viruses
    • Oncology
  • Investors
    • Overview
    • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
      • Investment Calculator
    • Corporate Governance
      • Highlights
      • Board of Directors
      • Management Team
      • Committee Composition
    • Press Releases
    • Events and Presentations
      • Events and Presentations
      • Event Calendar
      • Past Events
    • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • Investor Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Sep 1, 2021
Document Date
Sep 1, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Cidara Therapeutics, Inc.
Issuer
CIDARA THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Investors

  • Overview
  • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historical Lookup
    • Investment Calculator
    • Tax Filings
  • Corporate Governance
    • Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
  • Press Releases
  • Events and Presentations
    • Past Events
  • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • Investor Contact

Shareholder Tools

  • Print
  • RSS Feeds
  • Email Alerts

Contact Us

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121

p: (858) 752-6170
e: info@cidara.com

Footer Nav

  • About
  • Pipeline
  • Rezafungin
  • Cloudbreak®
  • Publications
  • Newsroom
  • Investors
  • Careers

Social Media

  • SUBSCRIBE

© 2022 Cidara Therapeutics, Inc. | Terms of Use | Privacy and Cookies Policy

Corporate Menu

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Careers
  • Pipeline
  • Rezafungin
    • Overview
    • Treatment
    • Prevention
    • Expanded Access Policy
  • Cloudbreak®
    • Overview
    • Influenza
    • HIV, RSV, SARS-CoV-2 and other viruses
    • Oncology
  • Investors
    • Overview
    • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
      • Investment Calculator
    • Corporate Governance
      • Highlights
      • Board of Directors
      • Management Team
      • Committee Composition
    • Press Releases
    • Events and Presentations
      • Events and Presentations
      • Event Calendar
      • Past Events
    • Analyst Coverage
    • Shareholder Services
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • Investor Contact

Secondary Header Menu

  • Publications
  • Newsroom
  • Careers
  • Contact

Social Media